421 related articles for article (PubMed ID: 16465418)
1. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
2. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma.
Oya M; Horiguchi A; Mizuno R; Marumo K; Murai M
Clin Cancer Res; 2003 Mar; 9(3):1021-7. PubMed ID: 12631601
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M
Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
7. Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells.
Aguilar-Morante D; Cortes-Canteli M; Sanz-Sancristobal M; Santos A; Perez-Castillo A
Neuroscience; 2011 Mar; 176():110-9. PubMed ID: 21185356
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors.
Malakootian M; Mowla SJ; Saberi H; Asadi MH; Atlasi Y; Shafaroudi AM
Mol Carcinog; 2010 Sep; 49(9):818-25. PubMed ID: 20572164
[TBL] [Abstract][Full Text] [Related]
10. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
[TBL] [Abstract][Full Text] [Related]
13. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.
Singh R; Sharma MC; Sarkar C; Singh M; Chauhan SS
FEBS J; 2014 Mar; 281(6):1629-41. PubMed ID: 24472318
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of CCAAT/enhancer binding protein-beta in the production of plasma proteins in yolk sac tumor.
Hirashiki K; Kishimoto T; Ishiguro H; Nagai Y; Furuya M; Sekiya S; Ishikura H
Exp Mol Pathol; 2005 Jun; 78(3):247-56. PubMed ID: 15924879
[TBL] [Abstract][Full Text] [Related]
17. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
18. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-β and CCAAT/enhancer-binding homologous protein.
Venza M; Visalli M; Alafaci C; Caffo M; Caruso G; Salpietro FM; Tomasello F; Teti D
Neurosurgery; 2011 Sep; 69(3):713-21; discussion 721. PubMed ID: 21471847
[TBL] [Abstract][Full Text] [Related]
20. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
